Skip to main content
Clinical Trials/NL-OMON42933
NL-OMON42933
Completed
Not Applicable

Pilot study: Biomarkers for the diagnosis of severe neutrophil inflammatory asthma. - Biomarkers for severe neutrophil inflammatory asthma

Rijnstate Ziekenhuis0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Rijnstate Ziekenhuis
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Rijnstate Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • All patients included in this study suffer from severe asthma. When a diagnosis of asthma is confirmed and comorbidities have been addressed, severe asthma is defined as asthma which requires treatment with high dose inhaled corticosteroids (ICS) plus a second controller (and/or systemic CS) to prevent it from becoming \*uncontrolled\* or which remains \*uncontrolled\* despite this therapy.

Exclusion Criteria

  • \-People suffering from other (chronic, pulmonary or autoimmune) diseases than asthma
  • \-People suffering from an upper or lower respiratory infection within four weeks prior to investigation
  • \-People having an immunodeficiency
  • \-People taking antibiotics (macrolide trial included) or probiotics, four weeks prior to investigation
  • \-People taking oral corticosteroids
  • \-People who smoke.

Outcomes

Primary Outcomes

Not specified

Similar Trials